McMinn Rachel

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 8%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
McMinn Rachel's trades of Neurogene Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
230.85
Quantity 70,839 -47.9%
Value US$722,923
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
245.34
Quantity 25,095 -30.6%
Value US$2,661,616
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26
US Neurogene Inc (NGNE)
S Sale
70,839 -47.9%
230.85
US$722,923 		70,839 -47.9% 230.85 US$722,923
2024-11-25 2024-11-22
US Neurogene Inc (NGNE)
B Purchase
25,095 -30.6%
245.34
US$2,661,616 		25,095 -30.6% 245.34 US$2,661,616